InMed Pharmaceuticals (INM) Intangibles (2020 - 2026)

InMed Pharmaceuticals' Intangibles history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• On a quarterly basis, Intangibles fell 9.79% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 9.79% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, down 44.64% from the prior year.
• Intangibles declined to $1.5 million in Q1 2026 per INM's latest filing, from $1.5 million in the prior quarter.
• Across five years, Intangibles topped out at $2.9 million in Q3 2023 and bottomed at $300000.0 in Q2 2023.
• The 5-year median for Intangibles is $1.7 million (2024), against an average of $1.9 million.
• Across the five-year window, Intangibles plunged 85.77% in 2023 and jumped 875.81% in 2024, its largest moves.
• Year by year, Intangibles stood at $2.0 million in 2022, then soared by 44.43% to $2.9 million in 2023, then sank by 41.89% to $1.7 million in 2024, then declined by 9.56% to $1.5 million in 2025, then fell by 2.61% to $1.5 million in 2026.
• Per Business Quant, the three latest INM Intangibles figures stand at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.6 million (Q3 2025).